Abstract CT120: AK104, a PD-1/CTLA-4 bispecific antibody in combination with chemotherapy as first-line therapy in a phase Ib trial in patients (pts) with advanced gastric (G) or gastroesophageal junction (GEJ) cancer
Authors: Jiafu Ji
Published: 2020-09-04
DOI:
10.1158/1538-7445.am2020-ct120
Source:
Full article
Abstract
Abstract